Rx Guaifenesin Ban Justified By Compliance Policy Guide – Adams Labs
This article was originally published in The Tan Sheet
Executive Summary
FDA should notify federal agencies that Rx single-ingredient, extended-release guaifenesin drugs are no longer available for contract purchase, Mucinex marketer Adams Labs says in Nov. 22 comments